176 related articles for article (PubMed ID: 34400266)
1. Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.
Dragojevic S; Ji J; Singh PK; Connors MA; Mutter RW; Lester SC; Talele SM; Zhang W; Carlson BL; Remmes NB; Park SS; Elmquist WF; Krishnan S; Tryggestad EJ; Sarkaria JN
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):e54-e62. PubMed ID: 34400266
[TBL] [Abstract][Full Text] [Related]
2. ATM as a target for novel radiosensitizers.
Sarkaria JN; Eshleman JS
Semin Radiat Oncol; 2001 Oct; 11(4):316-27. PubMed ID: 11677656
[TBL] [Abstract][Full Text] [Related]
3. Ataxia-telangiectasia mutated and the Mre11-Rad50-NBS1 complex: promising targets for radiosensitization.
Kuroda S; Urata Y; Fujiwara T
Acta Med Okayama; 2012; 66(2):83-92. PubMed ID: 22525466
[TBL] [Abstract][Full Text] [Related]
4. Combined ataxia telangiectasia mutated and DNA-dependent protein kinase inhibition radiosensitizes Madin-Darby canine kidney cells.
Koike M; Yutoku Y; Koike A
J Vet Med Sci; 2022 Nov; 84(11):1485-1490. PubMed ID: 36104184
[TBL] [Abstract][Full Text] [Related]
5. Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80.
Xiao M; Li X; Su Y; Liu Z; Han Y; Wang S; Zeng Q; Liu H; Hao J; Xu B
Cancer Biol Med; 2020 Aug; 17(3):640-651. PubMed ID: 32944396
[No Abstract] [Full Text] [Related]
6. DNA-dependent protein kinase regulates DNA end resection in concert with Mre11-Rad50-Nbs1 (MRN) and ataxia telangiectasia-mutated (ATM).
Zhou Y; Paull TT
J Biol Chem; 2013 Dec; 288(52):37112-25. PubMed ID: 24220101
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal Cancer.
Callaghan CM; Abukhiran IM; Masaadeh A; Van Rheeden RV; Kalen AL; Rodman SN; Petronek MS; Mapuskar KA; George BN; Coleman MC; Goswami PC; Allen BG; Spitz DR; Caster JM
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):933-944. PubMed ID: 36228747
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an NBS1 C-terminal peptide that can inhibit ataxia telangiectasia mutated (ATM)-mediated DNA damage responses and enhance radiosensitivity.
Cariveau MJ; Tang X; Cui XL; Xu B
Mol Pharmacol; 2007 Aug; 72(2):320-6. PubMed ID: 17507690
[TBL] [Abstract][Full Text] [Related]
9. Sensitization to radiation and alkylating agents by inhibitors of poly(ADP-ribose) polymerase is enhanced in cells deficient in DNA double-strand break repair.
Löser DA; Shibata A; Shibata AK; Woodbine LJ; Jeggo PA; Chalmers AJ
Mol Cancer Ther; 2010 Jun; 9(6):1775-87. PubMed ID: 20530711
[TBL] [Abstract][Full Text] [Related]
10. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks.
Dong J; Zhang T; Ren Y; Wang Z; Ling CC; He F; Li GC; Wang C; Wen B
Oncotarget; 2017 Apr; 8(14):22662-22673. PubMed ID: 28186989
[TBL] [Abstract][Full Text] [Related]
12. Repair-independent functions of DNA-PKcs protect irradiated cells from mitotic slippage and accelerated senescence.
Liu Y; Efimova EV; Ramamurthy A; Kron SJ
J Cell Sci; 2019 Jul; 132(13):. PubMed ID: 31189537
[TBL] [Abstract][Full Text] [Related]
13. DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated.
Matsumoto Y; Asa ADDC; Modak C; Shimada M
Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440313
[TBL] [Abstract][Full Text] [Related]
14. The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells.
Haykal J; Geara F; Haddadin MJ; Smith CA; Gali-Muhtasib H
Radiat Oncol; 2009 Jul; 4():25. PubMed ID: 19594955
[TBL] [Abstract][Full Text] [Related]
15. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.
Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K
Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine.
Sarkaria JN; Busby EC; Tibbetts RS; Roos P; Taya Y; Karnitz LM; Abraham RT
Cancer Res; 1999 Sep; 59(17):4375-82. PubMed ID: 10485486
[TBL] [Abstract][Full Text] [Related]
17. Ataxia-telangiectasia mutated kinase (ATM) as a central regulator of radiation-induced DNA damage response.
Tichý A; Vávrová J; Pejchal J; Rezácová M
Acta Medica (Hradec Kralove); 2010; 53(1):13-7. PubMed ID: 20608227
[TBL] [Abstract][Full Text] [Related]
18. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Golding SE; Rosenberg E; Valerie N; Hussaini I; Frigerio M; Cockcroft XF; Chong WY; Hummersone M; Rigoreau L; Menear KA; O'Connor MJ; Povirk LF; van Meter T; Valerie K
Mol Cancer Ther; 2009 Oct; 8(10):2894-902. PubMed ID: 19808981
[TBL] [Abstract][Full Text] [Related]
19. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.
Stewart GS; Last JI; Stankovic T; Haites N; Kidd AM; Byrd PJ; Taylor AM
J Biol Chem; 2001 Aug; 276(32):30133-41. PubMed ID: 11382771
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
